This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mauriello, A. Articles by Spagnoli, L. G. Search for Related Content PubMed PubMed Citation Articles by Mauriello, A. Articles by Spagnoli, L. G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

(Hypertension. 1996;28:177-182.)
© 1996 American Heart Association, Inc.

Articles

Effect of Long-term Treatment With Propionyl-L-Carnitine on Smooth Muscle Cell Polyploidy in Spontaneously Hypertensive Rats

Alessandro Mauriello; Giuseppe Sangiorgi; Augusto Orlandi; Stefania Schiaroli; Sabina Perfumo; Luigi Giusto Spagnoli

the Cattedra di Anatomia Patologica, Universita' di Roma Tor Vergata, Rome, Italy, and Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn (G.S.).

Experimental studies suggest that DNA content is increased in the smooth muscle cells of the arteries of hypertensive animals. It is unclear whether an increase in DNA content occurring in the smooth muscle cells of hypertensive rats represents a pressure-dependent effect. To evaluate the antihypertensive effect of long-term treatment with propionyl-L-carnitine and the possible morphological changes in thoracic smooth muscle cells correlated with this effect, we studied 4-month-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) randomly divided into five groups. One group of SHR was treated with propionyl-L-carnitine for 12 months; the other four groups of SHR and WKY received no treatment and were controls. We used static and flow cytometry to evaluate the polyploid cell content in thoracic aorta smooth muscle cells. Systolic pressure in untreated SHR progressively increased during the experiment. Treatment did not significantly influence pressure values in SHR. In WKY, blood pressure was significantly lower than that in treated and untreated age-matched SHR (2P<.02). The number of polyploid smooth muscle cells was significantly lower in the propionyl-L-carnitine–treated SHR than in the untreated rats (2P<.04) and similar to values for WKY. The reduction of polyploid cells in treated SHR was paralleled by a significant decrease of the aortic total DNA content, whereas no modifications occurred in smooth muscle cell mass. Long-term treatment with propionyl-L-carnitine may interfere with cellular mechanisms regulating the secondary responses involved in DNA synthesis.

Key Words: polyploidy • antihypertensive agents • propionyl-L-carnitine • rats, inbred SHR

This article has been cited by other articles:

				S. M. Fenkci, V. Fenkci, O. Oztekin, S. Rota, and N. Karagenc Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome Hum. Reprod., July 1, 2008; 23(7): 1602 - 1606. [Abstract] [Full Text] [PDF]